Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

By | October 27, 2021
Israeli researchers evaluate the antibody response in ICPs to assess antibody-mediated immunity following vaccination with the Pfizer-BioNTech vaccine.